Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 23, 2014 - Issue 10
Submit an article Journal homepage
482
Views
16
CrossRef citations to date
0
Altmetric
Drug Evaluations

Sirukumab: a novel therapy for lupus nephritis?

Uma ThanarajasingamDivision of Rheumatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
&
Timothy B NiewoldDivision of Rheumatology and Immunology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA+1 507 284 8450; +1 507 284 0564; [email protected]
Pages 1449-1455 | Published online: 05 Sep 2014

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jorge Medina-Rosas, Hanan Al-Rayes, Ahmed T. Moustafa & Zahi Touma. (2016) Recent advances in the biologic therapy of lupus: the 10 most important areas to look for common pitfalls in clinical trials. Expert Opinion on Biological Therapy 16:10, pages 1225-1238.
Read now
Mariana Postal, Nailú Angélica Sinicato, Simone Appenzeller & Timothy B. Niewold. (2016) Drugs in early clinical development for Systemic Lupus Erythematosus. Expert Opinion on Investigational Drugs 25:5, pages 573-583.
Read now

Articles from other publishers (14)

Farah Abuazzam, Casey Dubrawka, Tarek Abdulhadi, Gwendolyn Amurao, Louai Alrata, Dema Yaseen Alsabbagh, Omar Alomar & Tarek Alhamad. (2023) Emerging Therapies for Antibody-Mediated Rejection in Kidney Transplantation. Journal of Clinical Medicine 12:15, pages 4916.
Crossref
Wenyan Cui, Yunfei Tian, Guangliang Huang, Xinhui Zhang, Feigao Li & Xiuju Liu. (2023) Clinical research progress of novel biologics for the treatment of lupus nephritis. Clinical and Experimental Medicine.
Crossref
Hao Cheng, Xiao-ying Zhang, Hui-dan Yang, Zhen Yu, Cheng-lan Yan, Chong Gao & Hong-yan Wen. (2022) Efficacy and safety of belimumab/low-dose cyclophosphamide therapy in moderate-to-severe systemic lupus erythematosus. Frontiers in Immunology 13.
Crossref
Selma Cecilia Scheffler Mendoza, Francisco Eduardo Rivas-Larrauri & Ana Luisa Rodríguez-Lozano. 2022. Common Pediatric Diseases: an Updated Review. Common Pediatric Diseases: an Updated Review 324 374 .
Zunlian Wang, Min Huang, Bin Yu, Yilan Huang, Silin Zheng, Xuping Yang & Hong Ning. (2021) Comparison of the efficacy and safety indicators of DMARDs for rheumatoid arthritis. Medicine 100:29, pages e26524.
Crossref
Bingyi Yang, Ming Zhao, Haijing Wu & Qianjin Lu. (2020) A Comprehensive Review of Biological Agents for Lupus: Beyond Single Target. Frontiers in Immunology 11.
Crossref
Zaid W El-Husseini, Reinoud Gosens, Frank Dekker & Gerard H Koppelman. (2020) The genetics of asthma and the promise of genomics-guided drug target discovery. The Lancet Respiratory Medicine 8:10, pages 1045-1056.
Crossref
Linyu Geng, Xiaojun Tang, Shiying Wang, Yue Sun, Dandan Wang, Betty P. Tsao, Xuebing Feng & Lingyun Sun. (2020) Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus. Frontiers in Immunology 11.
Crossref
Hwee Siew Howe & Bernard Pui Lam Leung. (2019) Anti-Cytokine Autoantibodies in Systemic Lupus Erythematosus. Cells 9:1, pages 72.
Crossref
Dandan Wang, Saisai Huang, Xinran Yuan, Jun Liang, Renju Xu, Genhong Yao, Xuebing Feng & Lingyun Sun. (2015) The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus. Cellular & Molecular Immunology 14:5, pages 423-431.
Crossref
Laurie S. Davis & Andreas M. Reimold. (2017) Research and therapeutics—traditional and emerging therapies in systemic lupus erythematosus. Rheumatology 56:suppl_1, pages i100-i113.
Crossref
Yongkang Wu, Bei Cai, Junlong Zhang, Beilei Shen, Zhuochun Huang, Chunyu Tan, Carla C. Baan & Lanlan Wang. (2017) IL-1 β and IL-6 Are Highly Expressed in RF+IgE+ Systemic Lupus Erythematous Subtype . Journal of Immunology Research 2017, pages 1-8.
Crossref
Rufei Lu, Melissa E. Munroe, Joel M. Guthridge, Krista M. Bean, Dustin A. Fife, Hua Chen, Samantha R. Slight-Webb, Michael P. Keith, John B. Harley & Judith A. James. (2016) Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies. Journal of Autoimmunity 74, pages 182-193.
Crossref
Timo Rath, Ulrike Billmeier, Maximilian J. Waldner, Raja Atreya & Markus F. Neurath. (2015) From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesis. Archives of Toxicology 89:4, pages 541-554.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.